News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
245 Results
Type
Article (53)
Press Release (192)
Section
Business (59)
Deals (11)
Drug Development (88)
FDA (4)
Job Trends (2)
News (122)
Policy (14)
Tag
Alliances (13)
Approvals (3)
Artificial intelligence (1)
Best Places to Work (2)
Cancer (1)
Cardiovascular disease (1)
Cell therapy (1)
Clinical research (80)
Collaboration (1)
COVID-19 (9)
Data (8)
Diagnostics (4)
Earnings (26)
Events (43)
Executive appointments (1)
FDA (4)
Funding (1)
Gene therapy (1)
GLP-1 (2)
Government (4)
Guidances (1)
Healthcare (5)
Immunology and inflammation (1)
Immuno-oncology (1)
Infectious disease (9)
Inflammatory bowel disease (2)
IPO (7)
JPM (1)
Liver cancer (1)
Manufacturing (1)
Medical device (4)
Medtech (4)
Mergers & acquisitions (3)
Metabolic disorders (1)
Neurodegenerative disease (1)
Neuropsychiatric disorders (1)
Neuroscience (1)
NextGen: Class of 2026 (2)
Obesity (1)
People (27)
Phase 1 (26)
Phase 2 (57)
Phase 3 (41)
Pipeline (3)
Preclinical (9)
Psychedelics (1)
Rare diseases (1)
Real estate (1)
Regulatory (12)
Startups (2)
Tariffs (1)
Venture capital (1)
Date
Last 30 days (1)
Last 365 days (30)
2026 (1)
2025 (32)
2024 (20)
2023 (30)
2022 (30)
2021 (30)
2020 (32)
2019 (6)
2018 (9)
2017 (27)
2016 (9)
2015 (13)
2014 (6)
Location
Asia (24)
Australia (4)
California (2)
Connecticut (1)
Europe (217)
Massachusetts (1)
Southern California (2)
United States (4)
245 Results for "abivax".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Abivax to be Added to Nasdaq Biotechnology Index
December 19, 2025
·
1 min read
Press Releases
Abivax Presents Third Quarter 2025 Financial Results
December 16, 2025
·
13 min read
Press Releases
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
December 18, 2025
·
14 min read
Press Releases
Abivax Presents First Half 2025 Financial Results
September 9, 2025
·
10 min read
Press Releases
Abivax Announces Launch of Public Offering
July 24, 2025
·
14 min read
Press Releases
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data
October 5, 2025
·
6 min read
Press Releases
Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
September 15, 2025
·
5 min read
Press Releases
Abivax Announces Closing of $747.5 Million Public Offering
July 29, 2025
·
9 min read
Press Releases
Abivax announces trading resumption of its ordinary shares on Euronext Paris
July 25, 2025
·
1 min read
Press Releases
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction Trial Results in Participants With and Without Prior Inadequate Response to Advanced Therapies
October 6, 2025
·
7 min read
1 of 25
Next
